CD BioScinces provides clinical trial services including bioanalytical lab testing, clinical pharmacology, first-in-human (FIH), proof of concept (POC), early phase trials, phase IIa trials, phase IIb ...

Torpedo Group Torpedo is where great ideas come to life. We’re a creative agency for the digital world, blending insight, ideas and technology to deliver multi-channel marketing programs that engage ...

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster.

We are 20:20 Selection. Over more than 10 years we have built our reputation in providing unrivalled professional medical recruitment services to both our clients and candidates. During that time we ...

Rock Unlimited: Solid science. Fluid thinking. Lasting change.

Direct Express is a well-established company based to the north of London – at Welham Green, Hertfordshire – which is close to the M25, M4, M3, M1 and A1(M).

AstraZeneca (AZ) has shared “unprecedented” overall survival (OS) results from a late-stage study of Imfinzi (durvalumab) ...

Eli Lilly has announced that the US Food and Drug Administration (FDA) has approved its targeted IL-13 inhibitor Ebglyss (lebrikizumab-lbkz) to treat moderate-to-severe atopic dermatitis (AD). The ...

Syneos Health Communications and Precision AQ led the agency list, while Novartis, Roche and Takeda shared the top client spot Over the course of 15 years, the PM Society Digital Awards have become a ...

Delivering on your brand or portfolio strategy can come with some sizeable questions that need to be tackled in order to progress. And not just progress but place you in the best position to achieve ...

Sanofi and Regeneron’s Dupixent (dupilumab) has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) as an add-on maintenance treatment for chronic obstructive pulmonary ...

Merck & Co – known as MSD outside the US and Canada – and Daiichi Sankyo’s investigational antibody-drug conjugate (ADC) ifinatamab deruxtecan has demonstrated promising results in a mid-stage lung ...